Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,721 | 2,521 | 3,795 | 1,533 | 1,561 |
| Operating Income | -3,721 | -2,521 | -3,795 | -1,533 | -1,561 |
| Other Income | 129 | 28 | 0 | 0 | 0 |
| Pre-tax Income | -3,592 | -2,493 | -3,795 | -1,533 | -1,561 |
| Income Tax | 6 | 5 | 5 | 2 | 2 |
| Net Income Continuous | -3,598 | -2,498 | -3,800 | -1,535 | -1,563 |
| Minority Interests | -22 | -18 | N/A | N/A | N/A |
| Net Income | $-3,576 | $-2,480 | $-3,800 | $-1,535 | $-1,563 |
| EPS Basic Total Ops | -0.24 | -0.18 | -0.27 | -0.11 | -0.11 |
| EPS Basic Continuous Ops | -0.24 | -0.18 | -0.27 | -0.11 | -0.11 |
| EPS Diluted Total Ops | -0.24 | -0.18 | -0.27 | -0.11 | -0.11 |
| EPS Diluted Continuous Ops | -0.24 | -0.18 | -0.27 | -0.11 | -0.11 |
| EBITDA(a) | $-3,720 | $-2,520 | $-3,794 | $-1,533 | $-1,561 |